| Identification | Back Directory | [Name]
L-Valinamide, L-valyl-L-lysyl-L-arginyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl-L-tryptophyl-L-arginyl-L-lysyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl- | [CAS]
1423743-97-8 | [Synonyms]
L-Valinamide, L-valyl-L-lysyl-L-arginyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl-L-tryptophyl-L-arginyl-L-lysyl-L-tryptophyl-L-lysyl-L-lysyl-L-tryptophyl- | [Molecular Formula]
C113H167N33O15 | [MOL File]
1423743-97-8.mol | [Molecular Weight]
2227.75 |
| Chemical Properties | Back Directory | [density ]
1.42±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [Sequence]
Val-Lys-Arg-Trp-Lys-Lys-Trp-Trp-Arg-Lys-Trp-Lys-Lys-Trp-Val-NH2 |
| Hazard Information | Back Directory | [Uses]
LZ1 peptide is a antimicrobial peptides with antimalarial activity[1][2]. | [References]
[1] Yaqun Fang, et al. In Vitro and In Vivo Antimalarial Activity of LZ1, a Peptide Derived from Snake Cathelicidin. Toxins (Basel). 2019, 11, 7. DOI:10.3390/toxins11070379
[2] Daniel J Cushing, et al. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Eur J Pharmacol. 2010, 635, 1-3. DOI:10.1016/j.ejphar.2010.03.016 |
|
|